SCHEMBL7577589

SCHEMBL7577589

N#Cc1ccc(C=O)cc1-c1ccccc1-c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 3/20 0.43
HPGD P15428 2/20 0.43
GALR3 O60755 1/20 0.43
GAA P10253 1/20 0.43
USP8 P40818 1/20 0.40
USP7 Q93009 1/20 0.40
ESR2 Q92731 1/20 0.40
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
MAOA P21397 4/20 0.39
MAOB P27338 3/20 0.38
ATM Q13315 1/20 0.38
AR P10275 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7571095 0.92 ALDH1A1 (0.46) KDM4EALDH1A1HPGDGALR3GAA
SCHEMBL7576990 0.83 TRIM24 (0.42) KDM4EALDH1A1HPGDGALR3GAA
SCHEMBL1261594 0.82 ALDH1A1 (0.43) KDM4EALDH1A1HPGDGALR3GAA
SCHEMBL7570617 0.81 AR (0.44) KDM4EALDH1A1HPGDGALR3GAA
SCHEMBL7576912 0.79 MCL1 (0.47) KDM4EALDH1A1MCL1PIM1
SCHEMBL7575302 0.79 AR (0.38) KDM4EALDH1A1HPGDGALR3GAA
SCHEMBL2572 0.78 ESR2 (0.59) KDM4EALDH1A1HPGDGALR3GAA
SCHEMBL7577326 0.78 AR (0.48) KDM4EALDH1A1HPGDGAAMAOA
SCHEMBL7571007 0.78 USP8 (0.37) KDM4EALDH1A1HPGDGALR3GAA
SCHEMBL12679777 0.77 USP8 (0.52) KDM4EALDH1A1HPGDGALR3GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020019527-A1 Substituted phenyl farnesyltransferase inhibitors ABBOTT LABORATORIES 2002-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019527-A1 Substituted phenyl farnesyltransferase inhibitors FNTA, FNTB, SLC10A1 KDM4E 3715/4885ALDH1A1 385/4885HPGD 943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.